Copanlisib With Rituximab-Bendamustine in Patients With Relapsed-Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT04433182 · TERMINATED
Trial details
- NCT number
- NCT04433182
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2024-12-19
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.